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Abstract
Introduction: Anorexia nervosa (AN) is a serious chronic psychosomatic disorder, the essence of
which are attempts by the sufferer to obtain a slim silhouette by deliberate weight loss (restrictive
diet,  strenuous  physical  exercise,  provoking  vomiting).  The  aetiology  of  this  disorder  is
multifactorial. Genetic factors that influence the predisposition to AN have been sought. A broad
meta-analysis  points  to  a  strong  genetic  correlation  between  AN  and  insulin  resistance.
Adiponectin (ADIPO) increases insulin sensitivity. In our pilot study we demonstrated that the
TT genotype in  locus ADIPOQ  c.276 G>T of the ADIPO gene and a higher concentration of
ADIPO in blood serum occurred significantly more frequently in 68 girls suffering from AN than
in 38 healthy girls. The objective of this study was to evaluate the frequency of the occurrence of
ADIPOQ c.45 T>G and ADIPOQ c.276 G>T in the ADIPO gene in a larger cohort of girls with
AN  and  healthy  girls,  as  well  as  an  analysis  of  correlations  between  variants  of  the
aforementioned polymorphisms and the levels of ADIPO in blood serum. 
Material and methods: The study covered 472 girls (age: 11–19 years): 308 with the restrictive
form of AN (AN) and 164 healthy girls (C). The level of ADIPO in blood serum was determined
by means of the ELISA method on a Bio-Vendor, LLC (Asheville, North Carolina, USA). The
DNA isolation  was  carried  out  by means  of  Genomic  Mini  AX BLOOD (SPIN).  The  PCR
reaction was carried out in a ThermoCycle T100 thermocycler. 80–150 ng of the studied DNA
and relevant F and R starters were added to the reaction mixture. The reaction products were
subjected to digestion by restriction enzymes and separated on agarose gels (RFLP). 
Results: The distribution of genotypes in the polymorphic site ADP c.45 of the ADIPO gene and
ADP c.276 was similar in both groups. In both groups the T allele was most frequent in locus
ADIPOQ c.45 and the G allele in locus ADIPOQ c.276. In all the study subjects collectively (AN
and C) a statistically significant negative correlation between the levels of ADIPO in blood serum
on one hand and body weight (r = –0.46; p < 0.0001) and BMI (r = –0.67; p < 0.0001) on the
other was demonstrated. Exclusively in the AN group a significant correlation between the level
of ADIPO in blood and the distribution of TG, TT, and GG alleles in  loci ADIPOQ c.45 and
ADIPOQ c.276 was demonstrated (p= 0.0052 and p< 0.0001, respectively).
Conclusions: The genotype in loci ADIPOQ c.45 and ADIPOQ c.276 of the ADIPO gene seems
to have no effect on the predisposition to AN. Girls suffering from AN with the TT genotype in
loci ADIPOQ c.45 and ADIPOQ c. 276 may demonstrate higher insulin sensitivity because they
have significantly higher levels of ADIPO than girls suffering from AN with other genotypes.
This may be suggestive of their better adaptation to the state of malnutrition, and it has a potential
effect on treatment results. 
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Introduction
Anorexia nervosa (AN) is a chronic medical condition of a psychosomatic nature, affecting ca.
1% of the population of girls and women aged 15–24 years [1]. The diagnostic criteria for AN are
provided in  Table  1  [2].  Anorexia  nervosa is  associated  with  a  high  risk of  serious  somatic
complications,  caused  by  chronic  starvation,  deep  malnutrition,  adipose  tissue  atrophy,  and
cachexia. Furthermore, it is also comorbid with many psychiatric disorders, such as depression,
anxiety, and personality disorders [3].
The aetiology of AN remains unclear; however, it  is broadly believed that the origins of this
condition  are  multifactorial.  Scholars  point  to  the  co-existence  of  certain  individual  factors
predisposing  to  AN: genetic  factors,  as  well  as  specific  personality  traits  and environmental
features: sociocultural, family-related, and socioeconomic. 
Studies on twins and families suggest that the development of AN is fostered by genetic factors
[4].  The concordance rate of AN in monozygotic  twins is  estimated at  55–56% vs. 5–7% in
dizygotic twins [5, 6]. A large, controlled study of families (1831 relatives, 504 probands with
AN) demonstrated that first-degree female relatives exhibit an at least 10-fold higher risk of AN
development than the general population [7]. Anorexia nervosa heritability is estimated at 48% to
88% [7], which warrants the search of genes predisposing to development of the disorder [7–10].
Linkage studies in eating disorders demonstrated that locus D1S3721 in the region 1p34.2 might
be  associated  with  the  restrictive  type  of  AN  [44].  Signals  for  AN  were  discovered  on
chromosomes 2, 3, 4, and 13. A detailed mapping of regions located on chromosome 1 allowed
the selection of genes of the receptor for serotonin HTR1D and the receptor for opioids OPRD1
as potential genes of AN susceptibility [11]. 
Many studies  have  been carried  out  in  search  of  AN candidate  genes  [12–15];  they do not,
however,  have  sufficient  statistical  power  due  to  small  numbers  of  subjects,  methodological
differences,  and  population  heterogeneity  [12].  For  example,  one  analysis  covered  genes  of
oestrogen receptors 1 and 2 (ESR1; ESR2 = ERβ), essential for female puberty, because AN is
much more frequent in girls than in boys, most often manifesting itself in adolescence [12]. The
analysis  focused  on  genes  participating  in  the  dopaminergic  and  serotoninergic  regulation,
because deviations in these systems had been demonstrated in the acute stage of the disease and
after recovery [16–19], and serotonin and dopamine affect eating habits, physical activity, and
mechanisms of reward [12]. Molecular studies on the genes of leptin, leptin receptor, downstream
protein coding genes towards the signal pathway of leptin — AGRP, ghrelin, GOAT, or studies
focusing  on  polymorphisms  of  the  gene  of  the  brain-derived  neurotrophic  factor  (BDNF),
similarly to other studies, have not provided firm evidence of their effect on eating disorders [20,
21]. 
Genome-wide association studies (GWAS), based on investigating the entire genome with no
preliminary hypotheses posed, suggest that AN is a polygenetic condition, with several dozen
gene variants  involved in  its  pathogenesis,  each  of  which  has  a  minor  effect  modifying the
susceptibility to AN [11]. 
A meta-analysis conducted by Duncan et al. [22] on the largest cohort of AN patients investigated
thus  far  (3495  subjects)  and  in  a  control  group  (10,982  subjects),  by  means  of  linkage
disequilibrium score regression, demonstrated that the strongest genetic correlation among all the
metabolic and mental phenotypes examined by these authors was a negative correlation between
anorexia nervosa and insulin resistance. Adiponectin (ADIPO) is mentioned among hormones
playing a  part  in  shaping insulin  sensitivity  [23–25].  The adiponectin  coding gene  ADIPOQ
(APM1), mapped in the region 3q27.3 and containing 4 exons, has high expression in mature,
differentiated adipocytes of the white, mostly visceral adipose tissue [26]. AdipoR1 and AdipoR2
demonstrate high expression, among others, in the paraventricular nucleus of the hypothalamus,
associated with the regulation of the feeling of hunger and satiety [27, 28]. ADIPO takes part in
the regulation of the energy homeostasis of the body, demonstrating activity that increases insulin
sensitivity and prevents diabetes, atherosclerosis, and inflammation, as well as the antiapoptotic,
antifibrotic, and proangiogenic activity [29–32].
Previous studies concerning the frequency of polymorphisms in ADIPO genes in AN patients are
scarce.  Křížova  et  al.  [33]  compared  the  frequency  of  polymorphic  variants  +45T>G  and
+276G>T in  the  Czech  population,  investigating  their  influence  on  the  level  of  adiponectin
circulating in blood and on metabolic phenotypes. Nevertheless, the studied groups were small
(28 females with AN and 38 healthy females). 
Our first attempt at assessing the frequency of polymorphisms in the adiponectin gene in the
Polish population was undertaken in 2017. We performed a pilot study of 68 girls suffering from
AN  and  38  healthy  control  females  [34],  showing  statistically  significant  differences  in  the
frequency of polymorphisms of the ADIPO gene between AN patients and controls. We observed
that the TT genotype in locus  ADIPOQ  c.276G>T occurs significantly more frequently in AN
patients. Therefore, it seemed justified to continue the research in a larger cohort. We assumed
that it may allow us to find the genetic variant predisposing to AN and help to understand the
pathogenesis of the disorder. 
The objective of the study is to assess the frequency of polymorphisms of ADIPOQ c.45T>G and
ADIPOQ  c.276G>T in  the  adiponectin  gene  in  girls  suffering  from anorexia  nervosa  and in
healthy subjects and to analyse correlations between variants of these polymorphisms and levels
of adiponectin in blood serum. 
Material and methods
The total of 472 girls (aged 11–19) from the region of Silesia were recruited to the study: 308
girls suffering from anorexia nervosa (AN) hospitalised in Independent Public Clinical Hospital
No. 1 in Zabrze, Medical University of Silesia in Katowice, and 164 healthy girls (C), secondary
school students from Zabrze and Gliwice. The criterion qualifying to the study for the AN group
was a diagnosis of the restrictive form of AN (according to ICD-10 [35] and DSM 5 [2]) and
informed consent to take part in the study given by the subject’s parents/legal guardians and by
the subject herself if aged > 16 years. The criteria qualifying to the study for the girls in the
control group were as follows: normal body weight, no chronic illnesses, no use of medications
over the previous month, no slimming diets and other methods of losing weight over the previous
3 months, and informed consent to take part in the study given by the subject’s parents/legal
guardians and by the subject herself if aged > 16 years.
The Bioethics Committee of the Medical University of Silesia in Katowice issued permission to
conduct the study (Decision No. KNW/0022/KB1/108/1/11 dated 20 September 2011).
Measurements of body weight and height and calculations of BMI and BMI-SDS were performed
for all the subjects, based on percentile grids applicable to the Polish population for the relevant
sex and age [36]. 
The molecular tests were carried out in the Department of Genetics (Institute of Psychiatry and
Neurology, Warsaw) with the use of DNA isolated from frozen samples of peripheral blood. The
isolation  was  obtained  by means  of  a  commercial  Genomic  Mini  Ax Blood Spin  kit  (A&A
Biotechnology, Gdynia, Poland). 
The analysis of selected polymorphisms in the gene of adiponectin (ADIPOQ) was performed
according to the following schedule: 
— amplification in the PCR reaction of a section of the gene containing a polymorphic locus.
The PCR reaction was conducted in the Thermo Cycle thermal cycler by Bio-Rad with the
application of the NXT Taq PCR kit by EURx, containing the following: hot start NXT
TaqDNA Polymerase, a reaction buffer, MgCl2, and dNTPs, and with the application of
relevant F and R starters. 80–150 ng of the DNA tested was added to the reaction mixture.
The reaction was conducted in 10 µL in the following conditions: 3 min. at 95°C, and
then 35 cycles: 30 seconds at 95°C, 30 seconds at 58°C, and 1 minute at 72°C. The final
stage was a 5-minute incubation of the product of the PCR reaction at 72°C;
— digesting the product of the PCR reaction with a restriction enzyme. The reaction was
conducted for 1 hour at a temperature of 30°C for SmaI, and at 37°C for Mva1269I;
— electrophoretic division of the digestion products obtained in the agarose gel containing
ethidium bromide;
— preparation of photographic documentation;
— statistical analysis of the obtained results. 
The starters applied and the selected restriction enzymes identifying the polymorphic loci
examined are listed below:
ADIPOQ gene polymorphism c.45 T > G
Starter F 5’– GAA GTA GAC TCT GCT GAG ATG G – 3’
Starter R 5’ – TAT CAG TGT AGG AGG TCT GTG ATG – 3’
Restrictive enzyme SmaI
ADIPOQ gene polymorphism c.276 G > T
Starter F 5’– GGC CTC TTT CAT CAC AGA CC – 3’
Starter R 5’ – AGA TGC AGC AAA GCC AAA GT – 3’
Restrictive enzyme Mva1269I
Statistical analysis 
The database was drawn up in an Microsoft Excel spreadsheet (Redmond, Washington,
USA). Statistical  calculations were performed using MedCalc software ver.  19.1.3 (MedCalc,
Ostend, Belgium). The level of p = 0.05 was considered significant. The following parameters of
the descriptive statistics were determined: arithmetic mean, median,  minimum and maximum
value,  lower  and  upper  quartile,  standard  deviation  (SD),  standard  error  (SE),  and  95%
confidence interval around the mean value. For all parameters the conformity of their distribution
with  the  normal  distribution  was  verified.  The  conformity  assessment  was  made  using  the
Shapiro-Wilk  test.  The  assessment  of  differences  between  the  means  was  performed  using
Student’s t-test with a separate evaluation of variances and the U Mann-Whitney test. A one-way
analysis of variances ANOVA was also performed. Homogeneity of variances was evaluated by
means of Levene’s test. 
The tests results were presented graphically as a box plot with a mean value and a 95%
confidence interval for the mean value marked as an error bar. An analysis of contingent tables
was performed for  qualitative  variables.  Descriptive  statistics  were calculated:  Pearson’s  chi-
square,  and the  significance  level  p,  C contingency coefficient.  The results  are  presented  in
graphic form by means of categorised histograms. 
Results
The average age of the girls in groups AN and C was similar (15.06 ± 1.57 years and 15.16 ±
2.12 years, respectively). The average body weight in the AN group was significantly lower (p <
0.05) than in the C group (40.21 ± 6.01 kg and 49.87 ± 7.93 kg, respectively). The average BMI
and BMI-SDS in girls suffering from AN was significantly lower (p < 0.05) than in healthy girls
(BMI: 15.19 ± 1.67 kg/m2  vs.  20.12 ± 2.46 kg/m2,  BMI-SDS: –2.53 ± 0.96 vs.  0.12 ± 1.06,
respectively) (Tab. 2). 
The average level of ADIPO in blood serum in girls suffering from AN was significantly higher
(p < 0.0001) than in the group of healthy girls (40.24 ± 6.76 µg/mL vs.  15.02 ± 5.87 µg/mL)
(Tab. 2; Fig. 1). 
The  allele  frequency  in  the  polymorphic  site  ADIPOQ  c.45 and  ADIPOQ  c.276 of  the
adiponectin gene (AN and C) is provided in Table 3. 
The most common allele arrangement in the polymorphic site ADIPOQ c.45 of the adiponectin
gene in girls suffering from AN was the TT genotype, similarly to the C group. The TG genotype
occurred  in  this  gene  with  a  similar  frequency  in  both  groups  (Tab.  3,  Fig.  2).  The  allele
arrangement in the polymorphic site  ADIPOQ c.276 of the adiponectin gene occurred with a
similar frequency in both groups (Tab. 3, Fig. 3).
The genotype distribution in the polymorphic site ADIPOQ c.45 of the adiponectin gene in both
groups did not differ statistically significantly (p = 0.2628), similarly to the polymorphic site
ADIPOQ c.276 (p = 0.6645). 
The frequency of individual alleles in polymorphic sites of ADIPOQ c.45 and ADIPOQ c.276 in
both groups was similar and no statistically significant differences were observed in this respect.
The T allele was more frequent in the polymorphic site  ADIPOQ c.45 and the G allele in the
polymorphic site ADIPOQ c.276 (Tab. 4, Fig. 4 and 5). 
In all  the studied girls  collectively (AN and C) a  statistically significant  negative correlation
between the levels of ADIPO in blood serum on the one hand and the body weight (r = –0.46; p <
0.0001) and BMI (r = –0.67; p < 0.0001) on the other was observed. No statistically significant
relationships between these parameters in individual studied groups (AN and C) were observed. 
An  analysis  of  correlations  between  the  levels  of  ADIPO in  blood  serum and the  genotype
distribution demonstrated a statistically significant relationship between the level of this hormone
in blood and the arrangement of TG, TT, and GG alleles in the polymorphic site ADIPOQ c.45
and the polymorphic site  ADIPOQ c.276 of the adiponectin gene (p = 0.0052 and p < 0.0001,
respectively) exclusively in girls with anorexia nervosa (Tab. 5, Fig. 6 and 7).
Discussion
In  the  Czech  population  the  authors  [33]  compared  the  frequency  of  individual  alleles  in
polymorphic sites ADIPOQ c.45 T>G and ADIPOQ c.276 G>T of the adiponectin gene in obese
subjects (BMI: 43.48 ± 1.12 kg/m2), in AN patients (BMI: 15.72 ± 0.36 kg/m2), and in healthy
females  (BMI:  22.32  ±  0.40  kg/m2).  In  subjects  suffering  from  anorexia  nervosa they
demonstrated, similarly to our study, that the T allele is more frequent in locus  ADIPOQ c.45
T>G (100% and 94.3%, respectively), the G allele is more frequent in locus ADIPOQ c.276 G>T
(71% and 64.6%, respectively). We studied the frequency of not only individual alleles in these
polymorphic sites but we also analysed the frequency of the genotypes. 
The genotype distribution in the polymorphic sites ADIPOQ c.45 T>G and ADIPOQ c.276 G>T
of the adiponectin gene in the studied girls with AN was not different from the distribution of
these  genotypes  in  healthy  subjects.  This  could  be  suggestive  of  the  fact  that  the  allele
arrangement  in  these  polymorphic  sites  has  no  influence  on  the  predisposition  to  anorexia
nervosa. 
We demonstrated significantly higher levels of ADIPO in blood serum in girls suffering from AN
as compared to healthy subjects (p < 0.0001). The concentration of ADIPO in blood correlates
negatively with the body weight and BMI in all the study subjects collectively (p < 0.0001).
Similar observations have been made by other authors [37–39] and by us in our pilot study [34].
Ziora  et  al.  [39]  demonstrated  that  the  group  of  girls  suffering  from AN (87  patients)  was
characterised by significantly (p < 0.0001) elevated levels of adiponectin (> 3.38 µg/mL) as
compared to the healthy subjects (61 girls). 
Delporte et al. [40] observed a 40% higher level of insulin sensitivity in a group of 26 females
suffering from AN than in a group of 24 healthy females. In both groups they demonstrated a
positive correlation between the level of ADIPO in blood and insulin sensitivity (p < 0.05) and a
negative correlation (p < 0.05) with the level of triglycerides, total cholesterol, LDL, and HDL.
They speculated that hyperadiponectinaemia in subjects suffering from AN might contribute to
maintaining the state of increased insulin sensitivity as one of adaptation mechanisms to deep
malnutrition. 
Housova et al. [4] demonstrated that ADIPO levels in blood serum correlate negatively with BMI
and are ca. 96% higher in the restrictive form of AN as compared to the control group. They did
not  observe  any  correlation  in  the  group  of  subjects  suffering  from  bulimia  nervosa.  They
suggested that increased levels of ADIPO in blood could reflect the reduced fat content in the
bodies of AN patients. 
We based our research assumptions on study results obtained by previous authors [42–44] who
analysed the  loci  in  the  ADIPO gene that  contain  functional  polymorphisms influencing the
modulation of insulin resistance. 
Japanese authors [42], who studied 480 healthy subjects and 384 subjects suffering from type 2
diabetes, observed that there is a relationship between polymorphisms of an individual nucleotide
in positions 45 (p = 0.003) and 276 (p = 0.002) in the ADIPO gene and type 2 diabetes. Patients
with the GG genotype in position 45 or 276 exhibited a much higher risk of type 2 diabetes than
subjects with the TT genotype.  Subjects with the GG genotype in position 276 had a higher
insulin resistance score than subjects with the TT genotype (1.61 ± 0.05 vs. 1.19 ± 0.12; p =
0.001). The G allele in position 276 was linearly related to lower levels of adiponectin in blood
serum (G/G: 10.4 ± 0.85 μg/mL, G/T: 13.7 ± 0.87 μg/mL, T/T: 16.6 ± 2.24 μg/mL; p = 0.01) in
individuals with a higher BMI. Individuals with the GG genotype in polymorphic site ADIPOQ
c.276  (the  putative  risk  gene)  had  lower  levels  of  adiponectin  in  blood  and  higher  insulin
resistance  than  individuals  with  the  TT  genotypes.  The  authors  concluded  that  this
polymorphism, located in the intron of the ADIPOQ gene, influences the change in the level of
expression of adiponectin,  and thereby the change of its  concentration in  blood serum. They
believe that  in  order  to  confirm it,  a  functional  study should be carried out  or  levels  of the
expression of ADIPO should be measured directly in the white adipose tissue from patients with
different genotypes in position ADIPOQ c.276. 
Such a study was carried out by Friedriksson et al. [43], evaluating the expression of mRNA for
adiponectin and the polymorphism  ADIPOQ c.276 G>T in 36 obese subjects without diabetes
(BMI:  41.5  ±  4.9  kg/m2).  mRNA expression  for  adiponectin  in  visceral  fat  was  positively
correlated with the level of adiponectin in blood serum (r = 0.54; p = 0.012). Carriers of the T
allele (GT and TT) had a significantly higher content of the adipose tissue as compared to carriers
of the GG genotype (65 ± 6 vs. 56 ± 10%; p = 0.011). Carriers of the GG genotype in locus
ADIPOQ c.276 had reduced glucose tolerance, and carriers of the GT and TT had a 38% higher
level of mRNA of adiponectin in the visceral adipose tissue (0.91 ± 0.06 for GT and TT vs. 0.66
± 0.09 for carriers of the GG genotype; p = 0.013). The authors believe that the genetic variation
in the ADIPO gene may influence the expression of the gene in the visceral adipose tissue, and
they suggest a potential role of such a variation in the regulation of fat accumulation in the body
of obese people. 
Other authors [44] evaluated haplotypes for two polymorphisms, 45T –> G and 276G –> T, and
their relationship with components of the metabolic syndrome and the level of ADIPO in blood in
413  subjects  —  representatives  of  the  Caucasian  race  without  diabetes.  Each  individual
polymorphism was positively correlated with insulin resistance. On the other hand, the haplotype
defined by these two co-existing polymorphisms was strongly associated with components of the
metabolic  syndrome.  Homozygotes  for  the  risk  haplotype  (carriers  of  the  TT  genotype  in
polymorphic site 45 and the GG genotype in polymorphic site 276) had a higher body weight (p
= 0.03), waist circumference (p = 0.004), systolic (p = 0.01) and diastolic blood pressure (p =
0.003), fasting glycaemia (p = 0.02), insulin (p = 0.005), insulin resistance score (HOMA) (p =
0.003), and total-cholesterol-to-HDL ratio (p = 0.01). Homozygotes had significantly lower levels
of adiponectin in blood serum (p = 0.03) irrespective of their sex, age, and body weight. In an
independent study conducted in a group of 614 Caucasian subjects, including 310 subjects with
type 2 diabetes, it was confirmed that the risk haplotype is associated with an increased body
weight  (p  =  0.03)  but  not  with  type  2  diabetes  itself.  The  authors  concluded  that  the
aforementioned variants in loci of adiponectin are associated with obesity and other features of
insulin resistance syndrome. However, considering the nature of the two SNPs, the risk haplotype
is probably a marker for linkage disequilibrium with a polymorphism so far unidentified, which
influences serum levels of adiponectin and insulin sensitivity [44]. 
We demonstrated a significant relationship in AN patients between the ADIPO level in blood and
the TG, TT, and GG allele arrangement in the polymorphic sites  ADIPOQ  c.45 and ADIPOQ
c.276. The  lowest  levels  of  adiponectin in  blood are  associated  with the  TG arrangement  in
position ADIPOQ c.45 and the GG arrangement in position ADIPOQ c. 276. The highest levels
of adiponectin in blood are associated with the TT genotype in both the studied loci. This may be
indicative of the fact that girls suffering from anorexia nervosa and having the homozygotic TT
arrangement of these loci of the adiponectin gene may demonstrate  higher insulin  sensitivity
because they have significantly higher levels of ADIPO than other girls with AN. 
Our study has several limitations. Association studies are usually planned to be carried out in
large populations to assure adequate power to the study. It is not an easy task, however, to recruit
individuals with conditions that are rare (and anorexia nervosa can be regarded as such) to take
part in any research. Because the availability of such patients is low, our study lasted several
years. The actual size of the group was decided having considered previous association studies
and adapting our technical and financial capacities. Another limitation to the study could also be
the fact that we determined the level of adiponectin in blood serum exclusively in the acute phase
of the illness, and not in all the subjects. Nevertheless, it seems that in this phase of the illness
numerous adaptive mechanisms to extreme malnutrition  can be fully observed.  On the other
hand, the number of subjects for whom we determined adiponectin levels in blood is sufficient
from the statistical point of view. 
Our study suggests that the genotype in the polymorphic sites ADIPOQ c.45 and ADIPOQ c.276
of the adiponectin gene seems to have no effect on the predisposition to anorexia nervosa. 
We conclude that girls suffering from anorexia nervosa with the TT genotype in loci ADIPOQ
c.45 and  ADIPOQ  c.  276 of the adiponectin gene may demonstrate higher insulin sensitivity
because they have significantly higher levels of adiponectin as compared to girls with anorexia
nervosa having different genotypes. It may be suggestive of their better adaptation to the state of
malnutrition,  possibly making them more treatment  resistant.  This,  however,  calls  for further
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Table 1. Diagnostic criteria for anorexia nervosa according to the American Psychiatric Society,
DSM-5 (2013 r.) [2]
A. Restriction of energy intake relative to requirements leading to a significantly low
body weight in the context of age, sex, developmental trajectory, and physical health.
Significantly low weight is defined as a weight that is less than minimally normal or,
for children and adolescents, less than that minimally expected.
B. Intense fear of gaining weight or becoming fat, or persistent behaviour that interferes
with weight gain, even though at a significantly low weight.
C. Disturbance in the way in which one's body weight or shape is experienced, undue
influence of body weight or shape on self-evaluation, or persistent lack of recognition
of the seriousness of the current low body weight.
Specify current type:
Restricting Type: during the last three months, the person has not engaged in recurrent episodes
of  binge  eating  or  purging  behaviour  (i.e.  self-induced  vomiting  or  the  misuse  of  laxatives,
diuretics, or enemas)
Binge-Eating/Purging Type: during the last three months, the person has engaged in recurrent
episodes  of  binge  eating  or  purging  behaviour  (i.e.  self-induced  vomiting  or  the  misuse  of
laxatives, diuretics, or enemas)
Table 2. Characteristics of examined girls with anorexia nervosa and healthy girls and the results
of serum adiponectin assessment
AN (n = 308) C (n = 164) 
Mean  SD (range) Mean  SD (range)
Age [years] 15.06  1.57 (11–19) 15.16  2.12          (11 - 19)
Height [cm] 162.47  6.47 (143.0–177.0) 160.31   7.06      (142.0  -
175.0)
Body weight [kg] 40.21  6.01 (18.7–54.8) 49.87*   7.93        (30.2 -
65.0)
BMI [kg/m2] 15.19  1.67 (9.11–18.6) 20.12*   2.46        (13.9 -
26.13)
BMI-SDS –2.53  0.96 (–5.49– –1.94) 0.12*  1.06 (–2.17–2.0)
Adiponectin
[µg/mL]
40.24 ± 6.76 (27.86–66.78) 15.02** ± 5.87 (4.19–29.83)
AN — girls with anorexia nervosa; C — healthy controls; SD — standard deviation; BMI —
body mass index; BMI- SDS — body mass index standard deviation score (subject’s BMI from
the mean BMI for age and gender); AN vs. C* p < 0.05; AN vs. C **p < 0.0001
Table 3. The genotype frequency in the polymorphic sites of the adiponectin gene (ADIPOQ c.45







n = 306 n = 161
p = 0.2628; c =.075  
TG 33 (10.8%) 25 (15.5%)
ADIPOQ c.45
TT 272 (88.9%) 136 (84.5%)
GG 1 (0.3%) 0 (0%)
n = 305 n = 160
p = 0.6645; c = 0.042
TG 124 (40.7%) 72 (45.0%)
ADIPOQ c.276
TT 46 (15.1%) 22 (13.8%)
GG 135 (44.2%) 66 (41.2%)
AN — group of girls with anorexia nervosa; C — healthy controls
Table 4. The allele frequency in the polymorphic sites of the adiponectin gene (ADIPOQ c.45







n = 306 n = 161
p = 0.2259; c = 0.04
ADIPOQ c.45 
T 577 (94.3%) 297 (92.2%)
G 35 (5.7%) 25 (7.8%)
n = 305 n = 161
p = 0.779; c = 0.01
ADIPOQ c.276 
T 216 (35.4%) 117 (36.3%)      
G 394  (64.6%) 205 (63.7%)
Table 5. Mean concentration  of  adiponectin  in  the  serum depending on the genotype  in  the
polymorphic site of the adiponectin gene (ADIPOQ c.45 and ADIPOQ c.276) in examined girls
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Figure 1.  Serum adiponectin concentrations [µg/mL] in girls with  anorexia nervosa (AN) and
healthy controls (C). AN vs. C p < 0.0001
Figure 2. Distribution of genotypes in locus ADIPOQ c.45 in girls with anorexia nervosa (AN)

































Figure 3. Distribution of genotypes in locus ADIPOQ c.276 in girls with anorexia nervosa (AN)


















Figure 4. Distribution of T and G alleles in ADIPOQ c.45 polymorphic site in girls with anorexia
nervosa (AN) and healthy controls (C) 
Figure  5.  Distribution  of  T and  G  alleles  in ADIPOQ  c.276 polymorphic  site in  girls  with





















Figure 6.  Correlation  between serum adiponectin  concentration  and genotype  distribution  in
ADIPOQ c.45 polymorphic site of adiponectin gene in girls with  anorexia nervosa (AN). P =
0.0052 
Figure 7. Correlation between adiponectin serum concentration and distribution of genotypes in
ADIPOQ c.276 polymorphic site in girls with anorexia nervosa (AN). p < 0.0001
